Stock Research for CRL

Current Price

$109.3400


Latest Update: 2018-02-23 16:00:00

High
$ 109.4400
Low
$ 109.2600
Close
$ 109.3300
Volume
16962
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

CRL Stock Chart & Research Data

The CRL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CRL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CRL Due diligence Resources & Stock Charts

The CRL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CRL Detailed Price Forecast - CNN Money CNN View CRL Detailed Summary - Google Finance
Yahoo View CRL Detailed Summary - Yahoo! Finance Zacks View CRL Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View CRL Trends & Analysis - Trade-Ideas Barrons View CRL Major Holders - Barrons
NASDAQ View CRL Call Transcripts - NASDAQ Seeking View CRL Breaking News & Analysis - Seeking Alpha
Spotlight View CRL Annual Report - CompanySpotlight.com OTC Report View CRL OTC Short Report - OTCShortReport.com
TradeKing View CRL Fundamentals - TradeKing Charts View CRL SEC Filings - Bar Chart
WSJ View Historical Prices for CRL - The WSJ Morningstar View Performance/Total Return for CRL - Morningstar
MarketWatch View the Analyst Estimates for CRL - MarketWatch CNBC View the Earnings History for CRL - CNBC
StockMarketWatch View the CRL Earnings - StockMarketWatch MacroAxis View CRL Buy or Sell Recommendations - MacroAxis
Bullish View the CRL Bullish Patterns - American Bulls Short Pains View CRL Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View CRL Stock Mentions - StockTwits PennyStocks View CRL Stock Mentions - PennyStockTweets
Twitter View CRL Stock Mentions - Twitter Invest Hub View CRL Investment Forum News - Investor Hub
Yahoo View CRL Stock Mentions - Yahoo! Message Board Seeking Alpha View CRL Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for CRL - SECform4.com Insider Cow View Insider Transactions for CRL - Insider Cow
CNBC View CRL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CRL - OTC Markets
Yahoo View Insider Transactions for CRL - Yahoo! Finance NASDAQ View Institutional Holdings for CRL - NASDAQ


Stock Charts

FinViz View CRL Stock Insight & Charts - FinViz.com StockCharts View CRL Investment Charts - StockCharts.com
BarChart View CRL Stock Overview & Charts - BarChart Trading View View CRL User Generated Charts - Trading View


Latest Financial News for CRL

Charles River Laboratories Announces New Tumor Model Compendium
Posted on Wednesday February 21, 2018

Charles River Laboratories International, Inc. recently announced the launch of its new online Tumor Model Compendium web interface. The new Compendium interface provides oncology researchers with an easily accessible, user-friendly resource to identify tumor models based on specific molecular and histological properties, accompanied by selected patient information.


See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.
Posted on Tuesday February 20, 2018

The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.


Market Trends Toward New Normal in Tile Shop Holdings, Cytokinetics, Limelight Networks, CatchMark Timber Trust, Global Payments, and Charles River Laboratories International — Emerging Consolidated Expectations, Analyst Ratings
Posted on Friday February 16, 2018

NEW YORK, Feb. 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tile ...


Wired News – Charles River Labs Inked an Agreement to Acquire MPI Research
Posted on Thursday February 15, 2018

Stock Monitor: Fluidigm Post Earnings Reporting LONDON, UK / ACCESSWIRE / February 15, 2018 / Active-Investors.com has just released a free research report on Charles River Laboratories International, ...


Charles River Labs buying Michigan firm for $800 million
The Boston Globe - Feb 13, 2018
Charles River Laboratories International Inc., a Wilmington company that contracts with drug and medical device makers to test products in mice and rats, said Tuesday that it will pay $800 million to buy a Michigan firm that does similar work.
Charles River Laboratories to Acquire MPI Research - Business Wire (press release)
MPI Research to sell to rival Charles River Laboratories in $800 million deal - MiBiz

Should You Expect Charles River Laboratories International Inc (NYSE:CRL) To ...
Simply Wall St - Feb 20, 2018
Charles River Laboratories International Inc (NYSE:CRL) delivered an ROE of 11.80% over the past 12 months, which is relatively in-line with its industry average of 11.08% during the same period.
Insider Trading Activity Charles River Laboratories Intl. Inc (NYSE:CRL ... - Market Exclusive
Q1 2018 Earnings Forecast for Charles River Laboratories Intl. Inc Issued By ... - The Ledger Gazette

Charles River Laboratories Announces New Tumor Model Compendium
Business Wire (press release) - Feb 21, 2018
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts.

Gabelli Comments on Charles River Laboratories Intl. Inc's FY2022 Earnings (CRL)
The Ledger Gazette - 14 hours ago
Charles River Laboratories Intl. (NYSE:CRL) last issued its quarterly earnings results on Tuesday, February 13th. The medical research company reported $1.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ...
Charles River Laboratories Intl. Inc (CRL) Shares Sold by Pembroke Management LTD - Dispatch Tribunal
Charles River Laboratories Intl. Inc (NYSE:CRL) Shares Sold by Hodges Capital ... - StockNewsTimes

Enter a stock symbol to view the stock details.